Navigation Links
Monroe, CT Gum Disease Treatment Can Now Potentially Reduce the Risk of Tooth Loss with the Use of the FDA-cleared Laser by Dr. Richard Amato
Date:7/24/2013

Monroe, CT (PRWEB) July 24, 2013

For Immediate Release-- Dr. Richard Amato now offers a new type of gum surgery to Connecticut patients who are at risk of loss of teeth due to gum disease. This FDA-cleared gum disease treatment, the Laser Assisted New Attachment Procedure or LANAP, offers patients many short-term and long-term benefits.

Unlike traditional periodontal surgery, LANAP does not involve any removal of gum tissue or stitches. Dr. Amato performs the procedure using the Periolase MVP-7 laser, which selectively removes the diseased tissue and kills the germs that cause gum infections while leaving healthy tissue unharmed. Teeth that are severely damaged and likely to be lost may be saved with LANAP.

The Periolase MVP-7 not only eliminates the bacteria that cause gum disease but also stimulates the bone, which has positive effects. When people have lost teeth, the loss of stimulation in the bone can lead to bone resorption, in which the bone gradually shrinks away. Stimulation is key to preventing this bone loss. For teeth that are loose, laser bone stimulation can help encourage repair and regeneration, improving the likelihood of the tooth remaining intact.

LANAP restores the mouth to a healthy state, protects against the immediate loss of more teeth, and helps guard against heart attack, stroke and diabetes. Another advantage of LANAP is that it creates a healthy environment for any future treatment that may be needed, like dental implants. Patients do not need to stop taking their daily aspirin or other anticoagulant medi
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Monroe, CT Dental Implants Are Now Computer Guided from Dr. Richard Amato for Precise Results
2. Monroe, CT Periodontist, Dr. Richard Amato, Prepares Patients for Dental Implants by Removing Gum Disease with the FDA Cleared Laser Gum Surgery
3. Monroe, CT Periodontist, Dr. Richard Amato Brings Modern Laser Gum Surgery to Local Patients Seeking Advanced Gum Disease Treatment
4. Connecticut Periodontist Dr. Richard Amato is Changing the Way Patients with Gum Disease in Monroe, CT Receive Gum Disease Treatment with Laser Surgery
5. Large study reveals increased cancer risks associated with family history of the disease
6. Fountain Valley, CA Gum Disease Treatment with Dr. Robert Mokbel Now Utilizes the FDA-cleared Laser to Stimulate Bone Growth and Can Prevent Tooth Loss
7. The Woodlands Dental Implants Can Have Improved Chances of Success by Removing Gum Disease with Laser Gum Surgery through Dr. Gayle Bradshaw
8. Increased Risk of Heart Disease Associated With Long-Term Obesity Article Published by Health News Wires
9. Latest Tylenol Liver Failure Lawsuit Allegations Report: Resource4thePeople Urges Consumers to Fully Inform Themselves about Liver Disease Danger Possibility
10. San Luis Obispo Gum Disease Treatment Can Prevent Bone and Tooth Loss with the New Laser Gum Surgery Option Offered by Dr. Michael Colleran
11. Falls Church, VA Dental Implants Can Be Improved by First Removing Gum Disease with the FDA Cleared Laser Gum Surgery Offered by Dr. William Doughterty
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... New York, NY (PRWEB) November 22, 2014 ... Australia’s Therapeutics Goods Administration (TGA) approved it for ... Glutathione was approved and listed within the Therapeutic ... http://www.comlaw.gov.au/Details/F2014L01277 , Kyowa Hakko’s Setria® Glutathione ... Chem, a biotech specialist that sources and imports ...
(Date:11/22/2014)... PITTSBURGH, PA (PRWEB) November 22, 2014 ... about the pain caused by the machine," said an ... injury, she had to go back a second time ... my invention idea." , She developed the patent-pending MAMO ... for breast cancer. The design saves the patient from ...
(Date:11/22/2014)... Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) that ... developed Type 2 diabetes due to its use continue ... underway in U.S. District Court, District of South Carolina, ... litigation will convene its next Status Conference on December ... Counsel for Plaintiffs and Defendants to meet and confer, ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 The Sports ... Roy Baroff to its team of conflict resolution ... soccer player, coach, and referee. He has over 30 years ... and beyond. , “I'm very excited to connect with SCI ... sports related interests to a program with a complete sports ...
(Date:11/22/2014)... 2014 Wright & Schulte LLC reports ... have been scheduled between October 2016 and April ... Illinois. U.S. District Judge Matthew F. Kennelly, who is ... Order (CMO) on November 6, 2014 that outlined the ... submit documents and other activities in preparation for the ...
Breaking Medicine News(10 mins):Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:SCI Announces New Team Member Roy Baroff 2Health News:SCI Announces New Team Member Roy Baroff 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4
... ‘Pneumonic plague’ is responsible for killing 100 people in eastern ... it has conducted. The authorities from WHO have said that ... also explained that the control measures have been hard to ... ,The outbreak had reportedly begun in mid-May. DR ...
... lives and affected 20,000 people in West Bengal's Dooars area ... West Bengal Assembly today. // ,Of the 20,000 ... malignant malaria, Das said during mention hour., ,Stating that ... it was far from adequate. Besides, there was no hospital ...
... Cadet Corps will soon sign an MoU with UN to ... in India, Director General of NCC M C Bhandari said ... the HIV infected that there were medicines for their treatment ... be ostracised, he told reporters here., ,Another MoU on ...
... distinct response of titillation when a person is exposed to ... University School of Medicine in St. Louis gauged the brainwave ... color slides, describing various scenes, the gamut ranging from water ... ,What they found may seem like a "no ...
... pancreatic surgery during the last 35 years at Johns ... J. Yeo, M.D., Samuel D. Gross Professor and chair ... University and Thomas Jefferson University Hospital in Philadelphia and ... that contrary to what many both in and out ...
... by the Mayo Clinic has revealed that acupuncture ... is a disorder considered disabling by many, and ... symptoms such as fatigue, joint stiffness and sleep ... are only partially effective. ,Mayo’s study involved ...
Cached Medicine News:Health News:Brain’s response distinct upon exposure to erotic image 2Health News:Brain’s response distinct upon exposure to erotic image 3Health News:Pancreatic Cancer Surgery Successful in 80-Year-Olds 2Health News:Pancreatic Cancer Surgery Successful in 80-Year-Olds 3Health News:Acupuncture to Relieve Fibromyalgia Symptoms 2
(Date:11/21/2014)... N.Y. , Nov. 21, 2014  Cardinal Health, ... world,s largest health care services companies, and Henry Schein, ... provider of health care products and services to office-based ... the companies have entered into a long-term strategic agreement ... product offerings to office-based medical practices.  This strategic agreement ...
(Date:11/21/2014)... N.J. , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... Krakauer , Chief Executive Officer, will be presenting at the ... New York Palace Hotel in New York ... 2014 at 2:00 PM ET. In addition, Mr. Krakauer and ... available for separate one-on-one meetings during the day. ...
(Date:11/21/2014)... Nov. 20, 2014  The acceptance of two ... AAGL Global Congress demonstrates continued interest in the ... provide bowel control. One of the abstracts, presented by ... Division Chief of Urogynecology and Reconstructive Pelvic Surgery ... Award for Best Written Abstract on Urogynecology/Pelvic Floor ...
Breaking Medicine Technology:Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3
... British Columbia--(BUSINESS WIRE)--Apr 3, 2007 - ... Company(TM),announced today the publication of new ... showing that Allon's product,candidate AL-108 significantly ... the hyperphosphorylation of tau protein in ...
... BASEL, Switzerland, April 3, 2007 (PRIME NEWSWIRE) ... microbiological and,pharmacokinetic profiles of Basilea's (SWX:BSLN) two ... for ceftobiprole, the first anti-MRSA broad-spectrum,cephalosporin in ... for the treatment of invasive fungal infections,yielded ...
Cached Medicine Technology:Allon Therapeutics to Present New Data at Leerink Swann Alzheimer's,Conference 2Allon Therapeutics to Present New Data at Leerink Swann Alzheimer's,Conference 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 2Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 4Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 5Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 6Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 7
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoScrew is a unipolar permanent pacing lead with a fixed screw a double flanch for permanent pacing. Due to latest technologies, VascoScrew D10/60 M is compatible to all pacemaker-cavities with th...
VascoTwist is a low profile unipolar permanent pacing lead with a retractable screw. Due to advanced technology VascoTwist 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm...
Medicine Products: